Dr. Patel is recognized for research that focuses on the role of endocannabinoids—a class of signaling molecules in the brain—in stress-induced neuroadaptation. His NIMH-funded project is testing the hypothesis that increasing endogenous brain cannabinoid levels via a novel pharmacological strategy could represent a potential treatment approach for mood and anxiety disorders.